Providers and payers say CMS' Meaningful Measures initiative is a step in the right direction, but uncertainties still remain around which measures actually matter.
The individual mandate to buy health insurance is out. Unpaid community service for unemployed workers who sign up for Medicaid is in.
MACRA's approach to reimbursing physicians is here, but many doctors and administrators are still trying to get a handle on how it works. Read on for tips on how to deal with this major change to the Medicare payment system.
As four not-for-profit health systems unveiled plans to create their own generic-drug company, experts say they'll face an uphill battle to make a significant dent in rising drug prices and shortages.
Health insurer Aetna has agreed to pay $17 million to settle claims that it breached the privacy of thousands of customers who take HIV medications.
The Trump administration is once again targeting substantial cuts to the Office of National Drug Control Policy. While some believe it could diminish the federal response to combating the opioid crisis, others say the move could help providers.
Pharmaceutical stocks dipped Thursday following the announcement that four large health systems will partner to create a not-for-profit generic drug company.
Scientists are hunting for a universal vaccine to protect against regular winter flu—and the next super-flu, too.
Lowe's employees are some of the 1 million people from self-insured employers and health plans who are customers of Accolade, which helps guide patients through the healthcare system.
About 91% of the ACOs in non-risk bearing tracks in 2016 would have saved an additional $966 million overall if they were in a contract with downside risk, according to an Avalere Health analysis released Thursday.
Healthcare has a cost problem. No one disputes that. But what many would dispute is the assertion that rapidly rising drug prices are the root cause of the problem. They are, as the latest data from the CMS and major hospital systems clearly show.